Overview
- DeepMind formally dismantled the dedicated AlphaFold team, a move first reported on Wednesday, July 29, 2026, that redirects the unit’s people and resources.
- Many former AlphaFold staff have been reassigned inside Alphabet to Gemini-driven work and to projects in enzyme design, genomics, nuclear fusion research, Code Strike, and Isomorphic Labs.
- Roughly 25% of the original AlphaFold paper authors have left DeepMind, and senior researchers including John Jumper, Jonas Adler, and Alexander Pritzel have joined Anthropic.
- AlphaFold’s prediction system and its public database of predicted protein structures remain accessible to researchers, but the company says active development under a dedicated team has effectively ended.
- The shift signals a strategic bet on generalist LLMs for scientific discovery and could concentrate AI-biology expertise at competitors, with potential effects on drug discovery workflows and the pace of targeted protein-research advances.